List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.5.2. Antileishmaniasis medicines | No observations |
PAHO Strategic Fund Medicine List | 2.7.1. Antileishmaniasis medicines |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |